Yes but didn’t they say TNBC was a long shot for
Post# of 147670
Doesn’t change that we need more trials, but why would Scott say some TNBC patients stoped getting Leronlimab after the trial was done once they went back and checked the information? Or he said something the the effect that not everyone was getting Leronlimab once it was done.
I’m confused as to why that would even happen to begin with.